Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Serological Tests for Covid-19: Potential Opportunities Publisher Pubmed



Tantuoyir MM1, 2, 3 ; Rezaei N1, 4, 5
Authors

Source: Cell Biology International Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus, caused a pandemic leading to a standstill of nearly all global activities. There are some controversies on the production of specific immunoglobulin M (IgM) and IgG antibodies after the infection with SARS-CoV-2. This paper seeks to elaborate on the potential application of IgM and IgG antibodies and the viral antigens for the diagnosis and the course of the disease as well as the recurrence of positive nucleic acid tests after discharge. © 2020 International Federation for Cell Biology
Related Docs
View other Related Docs
1. Seroprevalence of Immunoglobulin M and G Antibodies Against Sars-Cov-2 Virus: A Systematic Review and Meta-Analysis Study, Iranian Journal of Immunology (2021)
2. Covid-19: Significance of Antibodies, Human Antibodies (2020)
3. Serological and Molecular Tests for Covid-19: A Recent Update, Iranian Journal of Immunology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (11)
Alireza Ghanadan (1)
Other Related Docs
4. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
5. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
6. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
7. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
8. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
9. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
10. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
11. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
12. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm, Current Pharmaceutical Design (2021)
13. Dynamic Antibody Response: A Biomarker for Covid-19, Clinical Laboratory (2021)
14. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
15. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
16. A Review on the Diagnostic Approaches of Covid-19 Infection; Features and Limitations, Journal of Isfahan Medical School (2021)
17. Investigating the Seroconversion Patterns of Specific Antibodies Against Various Antigens of Sars-Cov-2 in Hospitalized Covid-19 Patients and Vaccinated Individuals, Archives of Clinical Infectious Diseases (2024)
18. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
19. Simultaneous Detection of Sars-Cov-2 Igg/Igm Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2021)
20. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)